Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.70 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | GRM5 | P41594 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10143960 | 0.98 | ALDH1A1 (0.77) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 | |
| SCHEMBL4414127 | 0.98 | ALDH1A1 (0.77) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 | |
| SCHEMBL3427969 | 0.97 | ALDH1A1 (0.70) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 | |
| SCHEMBL1116630 | 0.93 | ALDH1A1 (0.78) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 | |
| Piperidine SCHEMBL3246198 | 0.90 | ALDH1A1 (0.67) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 | |
| SCHEMBL27368115 | 0.90 | GRM5 (0.62) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 | |
| SCHEMBL5783791 | 0.88 | ALDH1A1 (0.71) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 | |
| SCHEMBL12424958 | 0.86 | ALDH1A1 (0.69) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 | |
| SCHEMBL5083468 | 0.86 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 | |
| SCHEMBL19691212 | 0.86 | ALDH1A1 (0.69) | ALDH1A1SMN1; SMN2L3MBTL1HTTGRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3897866-B1 | AN ANTIMICROBIAL COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-11-05 | — | — | EP | claimed |
| US-12311044-B2 | Antimicrobial composition | CONOPCO, INC. (US) | 2025-05-27 | — | — | US | claimed |
| CN-119654130-A | Use of a composition for enhancing night repair related functions of skin | 联合利华知识产权控股有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-117915890-A | Deodorant composition | 联合利华知识产权控股有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-113242751-B | Antimicrobial compositions | 联合利华知识产权控股有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-111787903-B | Disinfectant composition | 联合利华知识产权控股有限公司 | 2023-08-15 | — | — | CN | claimed |
| US-20220087914-A1 | AN ANTIMICROBIAL COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2022-03-24 | — | — | US | claimed |
| EP-3897866-A1 | AN ANTIMICROBIAL COMPOSITION | Unilever IP Holdings B.V. (NL) | 2021-10-27 | — | — | EP | claimed |
| CN-113242751-A | Antimicrobial compositions | 联合利华知识产权控股有限公司 | 2021-08-10 | — | — | CN | claimed |
| WO-2020126347-A1 | AN ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2020-06-25 | — | — | WO | claimed |
| EP-3897866-B1 | AN ANTIMICROBIAL COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-11-05 | — | — | EP | disclosed |
| US-12311044-B2 | Antimicrobial composition | CONOPCO, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| CN-119654130-A | Use of a composition for enhancing night repair related functions of skin | 联合利华知识产权控股有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-113242751-B | Antimicrobial compositions | 联合利华知识产权控股有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-111787903-B | Disinfectant composition | 联合利华知识产权控股有限公司 | 2023-08-15 | — | — | CN | disclosed |
| WO-2008073461-A2 | ION CHANNEL MODULATORS | WYETH (US) | 2008-06-19 | — | — | WO | disclosed |
| US-20060276516-A1 | Nicotinamide Derivatives Useful as p38 Inhibitors | SMITHKLINE BEECHAM CORPORATION | 2006-12-07 | — | — | US | disclosed |
| US-20060264479-A1 | Nicotinamide Derivatives Useful as p38 Inhibitors | SMITHKLINE BEECHAM CORPORATION | 2006-11-23 | — | — | US | disclosed |
| US-7125898-B2 | Nicotinamide derivatives useful as p38 inhibitors. | SMITHKLINE BEECHAM CORPORATION (US) | 2006-10-24 | — | — | US | disclosed |
| US-20050176964-A1 | Nicotinamide derivatives useful as p38 inhibitors | GLAXOSMITHKLINE LLC | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12311044-B2 | Antimicrobial composition | DPM1, THPO, FPR1 | ALDH1A1 2349/4885SMN1; SMN2 4342/4885L3MBTL1 2696/4885 |
| US-20060264479-A1 | Nicotinamide Derivatives Useful as p38 Inhibitors | MAPK1, MAPK7, MAPK6 | ALDH1A1 723/4885SMN1; SMN2 1259/4885L3MBTL1 4018/4885 |
| US-20060276516-A1 | Nicotinamide Derivatives Useful as p38 Inhibitors | MAPK1, MAPK7, MAPK6 | ALDH1A1 723/4885SMN1; SMN2 1259/4885L3MBTL1 4018/4885 |
| US-20220087914-A1 | AN ANTIMICROBIAL COMPOSITION | THPO, BROX, FPR1 | ALDH1A1 2160/4885SMN1; SMN2 4373/4885L3MBTL1 2800/4885 |
| US-20050176964-A1 | Nicotinamide derivatives useful as p38 inhibitors | MAPK1, MAPK7, MAPK6 | ALDH1A1 723/4885SMN1; SMN2 1259/4885L3MBTL1 4018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.